Lina Altayeb

Lina Altayeb


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2024 in International Journal of Pharmacy Practice
Verified
Journal Article
Closed access
LALina Altayeb
Lina Altayeb
AZAlaa Zkriea
Alaa Zkriea
EIEman El Imam
Eman El Imam
KGKhansa GreebAlla
Khansa GreebAlla
RHRimah Hassan
Rimah Hassan
MWMayyada Wazaify
Mayyada Wazaify
Objectives: Pregabalin abuse is increasing in prevalence and is associated with significant harm. This study aimed to assess community pharmacists’ perceptions of pregabalin abuse and their recommendations to address this issue. Methods: This was a descriptive cross-sectional study conducted in the Omdurman locality, Khartoum in 2022. Community pharmacies were selected randomly and surveyed using a pre-tested and self-administered questionnaire held on a smartphone. Chi-squared and Fisher’s exact tests were run using the Statistical Package for Social Sciences version 26. Key Findings: A total of 172 community pharmacists completed the questionnaire (77.8% aged 22-30 years, 65.1% females, 79.1% holding bachelor’s degrees, and 57.6% having ≤ 5 years of work experience). Most participants (81.4%) perceived that they had observed pregabalin abuse in the last 6 months. Participants indicated that they were aware of the abuse potential of pregabalin (97.7%) and that they routinely dispensed pregabalin only by prescription (92.4%). Most participants reported that people they suspected of abusing pregabalin were mainly men (98.8%), aged 21–30 years (90.7%), and did not regularly visit the pharmacy (72.7%). Actions taken for such customers included stating the product was not available (64.0%) and refusing to dispense (56.4%). The most recommended solutions were raising community awareness about the risks and consequences of pregabalin abuse (35.8%) and maximizing pharmacists’ adherence to dispensing regulations (36.5%). Conclusions: Most pharmacists believed that they had observed pregabalin abuse and that it was increasing. They managed the situation primarily by reporting the drug was unavailable and refusing to dispense it. Effective community pharmacy-based interventions are strongly needed to tackle the issue of pregabalin abuse.

28 March 2025 in Sudan Journal of Medical Sciences
Verified
Journal Article
Closed access
PDF file
IAIslam Ahmed
Islam Ahmed
LALina Altayeb
Lina Altayeb
Background: Multimorbidity is linked with poor patient outcomes, polypharmacy, and treatment burden. Treatment burden is the workload needed by patients to manage their multiple chronic conditions. We aimed to assess treatment burden and its predictors in patients with multimorbidity at the internal medicine clinic of the Omdurman Teaching Hospital. Methods: This was a descriptive, cross-sectional study. Patients were eligible for inclusion if they were aged ≥55 years and had ≥2 self-reported chronic conditions. Treatment burden was measured through the Multimorbidity Treatment Burden Questionnaire (MTBQ). Multivariable logistic regression was used to predict the factors associated with a high treatment burden. SPSS V.26 was used for statistical analysis. Results: A total of 256 participants were recruited (the median age was 64 years, and 39.1% were men). About 47% of participants had more than three chronic conditions, with hypertension (89.5%) and diabetes (82.0%) being the most common. Eighty-one percent of the participants had a high treatment burden with a median score of 40.4 (28.8–51.9). Arranging appointments (83.7%), seeing several health professionals (83.5%), and collecting prescription medicines (83.2%) were perceived as difficult tasks. Aspects related to treatment (collection of, taking, and paying for medicines) were the most difficult as perceived by participants. Low education (OR = 10.46; CI 3.01–36.39; P = 0.000), living outside Khartoum (OR = 4.24; CI 1.22–14.73; P = 0.023), having more chronic conditions (OR = 1.75; CI 1.03-2.97; P = 0.038), and taking more regular medications (OR = 1.32; CI 1.09–1.61; P = 0.004) were independently associated with high treatment burden. Conclusion: A high treatment burden was common and was primarily incurred by difficulties in interacting with many healthcare providers and obtaining prescribed medicines. More attention should be given to assessing and supporting patients with multimorbidity to reduce the burden through organized and integrated healthcare services.

16 January 2026 in Discover Education
Verified
Journal Article
Open access
PDF file
LALina Altayeb
Lina Altayeb
MEMohammed K. Elseddig
Mohammed K. Elseddig
ASAbeer Saeed
Abeer Saeed
EMEmad Eldin Munsour
Emad Eldin Munsour
Ali Awadallah SaeedAli Awadallah Saeed
Ali Awadallah Saeed
NANissreen M. A. Alsayed
Nissreen M. A. Alsayed
Background The higher education system in Sudan has been jeopardized by the ongoing armed conflict; yet the impact on pharmacy education remains unclear. This study aimed to describe the conflict’s impact on pharmacy colleges and the strategies that were implemented to sustain educational activities. Methods This was a descriptive cross-sectional study. Pharmacy colleges were eligible for inclusion if they were officially registered with the Sudan Ministry of Higher Education and Scientific Research and had at least one student cohort enrolled before 15th April 2023. A key informant from each college (a faculty member with a senior leadership role, typically the dean or vice dean) was selected. A structured and self-administered questionnaire was developed, created on Google Forms and sent via WhatsApp, Telegram or email. SPSS version 27 was used for analysis. Results A response rate of 66.7% (22 out of 33 colleges) was obtained. The role of key informants was principally dean (63.6%) or vice dean (27.3%). More than half of key informants (59.1%) had over five years of work experience at their institutes. Damage to physical and technological infrastructure was reported in 77.3% and 63.6% of colleges, respectively. Financially, 72.7% of colleges lost a significant amount of funding or revenue and had to make significant cuts (59.1%). Most colleges (90.9%) did not receive emergency funding or financial assistance from international or national aid organizations. Pharmacy field training (68.2%), clinical teaching in hospitals (66.7%), and practical teaching (68.2%) were the most disrupted educational activities. Measures to resume theoretical teaching included online learning (77.3%), use of a safe original or alternative location (18.2%), and establishing national (13.6%) or international (13.6%) collaborative centers. Final assessments were delayed in 45.5% of the colleges. The conflict also affected research activities, where 45.5% of colleges had to make adjustments. Conclusion This conflict profoundly disrupted pharmacy education, significantly impairing infrastructure and academic continuity. Despite these challenges, institutions have exhibited resilience by employing adaptive strategies. Immediate assistance is required to rehabilitate this vital sector.

21 August 2026 in Pharmacy
Verified
Journal Article
Open access
PDF file
LALina Altayeb
Lina Altayeb
HTHend Talkhan
Hend Talkhan
RARayah Asiri
Rayah Asiri
RARawan Aloqran
Rawan Aloqran
ASArwa Al Saeed
Arwa Al Saeed
KOKhalid Orayj
Khalid Orayj
Objectives: This study aimed to assess pharmacy students’ curricular exposure to deprescribing, their attitudes and preparedness to perform core deprescribing steps, and their understanding of interprofessional roles in the deprescribing process. Methods: A cross-sectional online survey that included undergraduate pharmacy students in their fifth or sixth year of study, who were enrolled in Saudi universities during the academic year 2025/2026. A 43-item self-administered validated questionnaire was used. The independent-samples t-test was used to examine differences in attitudes and preparedness among participants via SPSS 27. Results: In total, 367 students from 23 universities participated in the study; 54.0% were female, and 62.1% were in their fifth year. Familiarity with the term ‘deprescribing’ was reported by 55.3% of participants. Participants demonstrated highly positive attitudes toward the benefits of deprescribing, moderate toward misconceptions, and low toward barriers, with mean percentage scores of 85.08%, 66.50%, and 41.93%, respectively. Participants indicated moderately positive perceptions toward the non-experiential curriculum preparedness to identify and practice deprescribing and self-perception of the ability to perform core deprescribing steps, with mean percentage scores of 70.2% and 77.24%, respectively. Statistically significant differences were observed in the perception of curriculum preparedness by gender (p = 0.038), familiarity with the term deprescribing (p < 0.001), and exposure to deprescribing in the required pharmacy curriculum (p < 0.001). Participants perceived clinical pharmacists as having the greatest role across most stages of the deprescribing process. Conclusions: Undergraduate pharmacy students in Saudi Arabia recognize the value of deprescribing but have limited curricular exposure and moderate perceived preparedness to deprescribe.

20 November 2026 in Medicine
Verified
Journal Article
Open access
SESara Mostafa Eladawy
Sara Mostafa Eladawy
Naglaa BazanNaglaa Bazan
Naglaa Bazan
AKarwa khaled
arwa khaled
LALina Altayeb
Lina Altayeb
RMRadwa Mohamed
Radwa Mohamed
EHEman Hamid
Eman Hamid
Peripheral neurological manifestations have been reported following Coronavirus disease 2019 (COVID-19) infection, whereas neuropathic symptoms after COVID-19 vaccination remain less well characterized. To evaluate self-reported neuropathic symptoms following COVID-19 vaccination and identify factors associated with postvaccination symptom reporting, while accounting for previous confirmed COVID-19 infection. This cross-sectional survey included adults recruited from university-affiliated settings. Data were collected using a structured English/Arabic questionnaire covering COVID-19 infection, vaccination history, comorbidities, medication use, and neuropathic symptoms, including tingling, numbness, burning sensation, and electric shock–like sensations. Participants who reported symptoms were invited for neurological clinical assessment. The primary outcome was self-reported neuropathic symptoms potentially suggestive of peripheral neuropathy following COVID-19 vaccination. Previous confirmed COVID-19 infection was treated as a potential confounder in multivariable analysis. A total of 1201 individuals were screened, of whom 1166 were included in the final analysis. Postvaccination self-reported neuropathic symptoms were reported by 472 of 1090 vaccinated participants (43.3%). Following the first vaccine dose, symptom reporting differed significantly by vaccine type ( P < .001), with the highest proportions observed among recipients of Oxford-AstraZeneca COVID-19 vaccine (190/316 [60.1%]) and Sputnik V COVID-19 vaccine (37/92 [40.2%]). In multivariable analysis, older age, use of medications with reported or potential associations with peripheral neuropathy, and receipt of ChAdOx1-S, Gam-COVID-Vac, or Sinovac-CoronaVac were associated with increased post-vaccination symptom reporting ( P < .05), whereas previous confirmed COVID-19 infection was not independently associated with the outcome. In exploratory booster-dose analysis, homologous booster vaccination was associated with lower odds of symptom reporting than heterologous boosting (adjusted odds ratio 0.38, P < .001). Self-reported neuropathic symptoms were frequently reported following COVID-19 vaccination and varied according to vaccine type. Older age, selected vaccine types, and heterologous booster schedules were associated with symptom reporting. These findings are hypothesis-generating and should be interpreted cautiously because they reflect self-reported symptoms rather than confirmed peripheral neuropathy diagnoses and were not routinely confirmed by objective neurological investigations.